Calmark Sweden AB participates in Medica in Germany
Calmark Sweden AB will participate in the medical technology fair Medica between November 13 and 17. Medica is one of the world's largest B2B fairs for medical technology companies with 4,500 exhibitors and over 80,000 visitors. The company will meet existing and potential distributors.
Medica is an annual B2B fair in Düsseldorf that gathers approx. 80,000 participants from more than 60 countries. Calmark will attend to meet its distributors and meet new potential distributors and partners.
"Medica is an important event during the autumn, an opportunity to meet most of our partners in one and the same place. We look forward to important and developing meetings", comments CEO Anna Söderlund
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
For more information about Calmark Sweden AB, please contact:
Anna Söderlund, CEO
Telefon: +46 70 214 98 93
E-post: anna.soderlund@calmark.se
www.calmark.se
Calmark Sweden AB is a medical technology company that manufactures and markets a point-of-care (POC) analysis method with easier and faster diagnostics of medical conditions in newborns. The unique test platform consists of a portable instrument and test cassettes for various biomarkers. The first test, Neo-Bilirubin, is CE marked and measures the bilirubin level in whole blood for jaundice detection in newborns. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter care chains. In less developed healthcare systems, the product offers a decision support which is currently lacking, since the access to hospital laboratories often is limited. Calmark aims to become the global leader in POC diagnostics for newborns and, in the long term, to offer all relevant tests for the first period of life. The B share is listed on the Spotlight Stock Market and is traded under the CALMA B ticker. Read more at www.calmark.se/eng/home.
Tags: